Citi Boosts Eli Lilly Price Target to $1,500 on Strong Weight Loss Outlook

Citi raises Eli Lilly’s price target to $1,500, citing growing dominance in the weight loss market after a Medicare and Medicaid access deal and over $40B in potential peak sales.